Hanmi Pharmaceutical Secures 1.9 Trillion Won Technology Export Deal

Hanmi Pharmaceutical announced a major technology export contract. The deal is valued at approximately 1.9 trillion won. The contract involves collaboration with a partner identified as G.. . The agreement marks a significant export for the South Korean firm. It reflects growing international demand for Hanmi’s pharmaceutical technologies. The transaction is expected to strengthen the company’s global presence. Analysts view the deal as a boost to the nation’s biotech sector. The partnership may lead to further cross‑border collaborations.